Rockefeller Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | -$1K | – | 3992 |
|
|
2022
Q4 | $1K | Sell |
100
-945
| -90% | -$9.45K | ﹤0.01% | 3784 |
|
|
2022
Q3 | $28K | Buy |
1,045
+406
| +64% | +$10.9K | ﹤0.01% | 2631 |
|
|
2022
Q2 | $8K | Buy |
639
+594
| +1,320% | +$7.44K | ﹤0.01% | 3266 |
|
|
2022
Q1 | $0 | Hold |
45
| – | – | ﹤0.01% | 4107 |
|
|
2021
Q4 | $0 | Sell |
45
-472
| -91% | – | ﹤0.01% | 4025 |
|
|
2021
Q3 | $14K | Hold |
517
| – | – | ﹤0.01% | 2747 |
|
|
2021
Q2 | $15K | Hold |
517
| – | – | ﹤0.01% | 2621 |
|
|
2021
Q1 | $14K | Buy |
+517
| New | +$14K | ﹤0.01% | 2459 |
|
|
2020
Q4 | – | Sell |
-314
| Closed | -$7K | – | 3036 |
|
|
2020
Q3 | $7K | Buy |
314
+115
| +58% | +$2.56K | ﹤0.01% | 2133 |
|
|
2020
Q2 | $5K | Sell |
199
-106
| -35% | -$2.66K | ﹤0.01% | 2119 |
|
|
2020
Q1 | $5K | Buy |
+305
| New | +$5K | ﹤0.01% | 1977 |
|